Roelof Rongen
2017
In 2017, Roelof Rongen earned a total compensation of $1.9M as Former Chief Executive Officer at Matinas BioPharma Holdings, a 233% increase compared to previous year.
Compensation breakdown
| Bonus | $160,000 |
|---|---|
| Option Awards | $1,322,224 |
| Salary | $383,333 |
| Total | $1,865,557 |
Rongen received $1.3M in option awards, accounting for 71% of the total pay in 2017.
Rongen also received $160K in bonus and $383.3K in salary.
Rankings
In 2017, Roelof Rongen's compensation ranked 5,845th out of 14,666 executives tracked by ExecPay. In other words, Rongen earned more than 60.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,845 out of 14,666 | 60th |
Division Manufacturing | 2,130 out of 5,770 | 63rd |
Major group Chemicals And Allied Products | 665 out of 2,074 | 68th |
Industry group Drugs | 514 out of 1,730 | 70th |
Industry Pharmaceutical Preparations | 407 out of 1,329 | 69th |
Source: SEC filing on September 24, 2018.
Rongen's colleagues
We found four more compensation records of executives who worked with Roelof Rongen at Matinas BioPharma Holdings in 2017.
2017
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
2017
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
2017
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
2017
Gary Gaglione
Matinas BioPharma Holdings